Measurement of tumor hypoxia in spontaneous canine sarcomas

被引:31
作者
Bruehlmeier, M [1 ]
Kaser-Hotz, B
Achermann, R
Bley, CR
Wergin, M
Schubiger, PA
Ametamey, SM
机构
[1] Cantonal Hosp Aarau, Dept Nucl Med, CH-5001 Aarau, Switzerland
[2] Univ Zurich, Sect Diagnost Imaging & Radiat Oncol, Vetsuisse Fac, Zurich, Switzerland
[3] Paul Scherrer Inst, Villigen, Switzerland
[4] ETH, Ctr Radiopharmaceut Sci, PSI, CH-5232 Villigen, Switzerland
[5] USZ, Villigen, Switzerland
关键词
F-18]fluoromisonidazole; hypoxia; positron emission tomography; spontaneous canine sarcoma;
D O I
10.1111/j.1740-8261.2005.00065.x
中图分类号
S85 [动物医学(兽医学)];
学科分类号
0906 ;
摘要
We used positron emission tomography (PET) with [F-18]fluoromisonidazole (118 F]FMISO) to study tumor hypoxia in six dogs with spontaneous sarcomas. The tumors were regarded as hypoxic if [F-18]FMISO uptake exceeded normal tissue radioactivity by 40% (tumor/muscle ratio > 1.4) or if kinetic analysis indicated a positive [F-18]FMISO tissue influx rate (K-i>O) by a Patlak plot. Using these criteria, we found hypoxia in a fibrosarcoma grade 11, an undifferentiated sarcoma, and an ostoeosarcoma, but not in a fibrosarcoma grade I, another osteosarcoma, and a myxosarcoma. In three animals, the tumor oxygen partial pressure (pO(2)) was also measured invasively using Eppendorf needle electrodes. In these cases, the Eppendorf measurements were confirmed by the [F-18]FMISO PET results. In addition, [O-15]H2O PET was performed in four dogs in order to assess tumor perfusion. Comparisons of the [F-18]FMISO with [O-15]H2O PET images in two cases showed that tumor hypoxia occurred in the tumor center with low perfusion, whereas perfusion was heterogeneous in a nonhypoxic tumor.
引用
收藏
页码:348 / 354
页数:7
相关论文
共 24 条
[1]  
Achermann R, 2002, IN VIVO, V16, P431
[2]   Oxygenation of spontaneous canine tumors during fractionated radiation therapy [J].
Achermann, RE ;
Ohlerth, SM ;
Bley, CR ;
Gassmann, M ;
Inteeworn, N ;
Roos, M ;
Schärz, M ;
Wergin, MC ;
Kaser-Hotz, B .
STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 (05) :297-305
[3]  
AIRLEY RE, 2000, PHARM J, V264, P666
[4]  
Bruehlmeier M, 2004, J NUCL MED, V45, P1851
[5]   Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays [J].
Chapman, JD ;
Engelhardt, EL ;
Stobbe, CC ;
Schneider, RF ;
Gerald, GE .
RADIOTHERAPY AND ONCOLOGY, 1998, 46 (03) :229-237
[6]  
CHAPPELL WR, 1991, ADV DRUG RES, V20, P1
[7]  
Dewhirst MW, 1996, BRIT J CANCER, V74, pS247
[8]   [18F]-EF5, a marker for PET detection of hypoxia:: synthesis of precursor and a new fluorination procedure [J].
Dolbier, WR ;
Li, AR ;
Koch, CJ ;
Shiue, CY ;
Kachur, AV .
APPLIED RADIATION AND ISOTOPES, 2001, 54 (01) :73-80
[9]   Intravascular HBO2 saturations, perfusion and hypoxia in spontaneous and transplanted tumor models [J].
Fenton, BM ;
Lord, EM ;
Paoni, SF .
INTERNATIONAL JOURNAL OF CANCER, 2001, 93 (05) :693-698
[10]   THE CONCENTRATION OF OXYGEN DISSOLVED IN TISSUES AT THE TIME OF IRRADIATION AS A FACTOR IN RADIOTHERAPY [J].
GRAY, LH ;
CONGER, AD ;
EBERT, M ;
HORNSEY, S ;
SCOTT, OCA .
BRITISH JOURNAL OF RADIOLOGY, 1953, 26 (312) :638-648